NCT02654470 - Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only) | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

September 28, 2021

Study Completion Date

September 28, 2021

Conditions

Non-valvular Atrial Fibrillation

Interventions

DEVICE

Watchman FLX

Patients who are receiving the Watchman FLX device

Trial Locations (17)

Cardiologicum Hamburg, Hamburg

Aarhus University Hospital, Aarhus

Hospices Civils de Lyon, Lyon

Elisabeth Krankenhaus, Essen

Cardio Vasculares Centrum Sankt Katharinen, Frankfurt

Cardioangiologisches Centrum Bethanien, Frankfurt

Uni Jena, Jena

Herzzentrum Universität Leipzig, Leipzig

Beaumont Hospital, Dublin

Ospedale San Raffaele, Milan

Ospedale San Francesco, Nuoro

St. Antonius Hospital, Nieuwegein

Clinical Hospital University of Medicine, Poznan

Hospital De La Santa Creu I Sant Pau, Barcelona

Hospital Virgen Macarena, Seville

Royal Sussex County Hospital, Brighton

John Radcliffe Hospital, Oxford